Dr. Weaver’s research focuses on the ecology, evolution, epidemiology and pathogenesis of mosquito-borne viral diseases, arbovirus‐mosquito vector interactions, and vaccine development for arboviral disease prevention. Current projects include emergence
mechanisms, pathogenesis and vector transmission of Zika and chikungunya viruses. Recently, his group has also focused on understanding the emergence of SARS-CoV-2 variants and evaluation of COVID vaccines. Dr. Weaver leads two NIH-funded centers: the
World Reference Center for Emerging Viruses and Arboviruses and the West African Center for Emerging Infectious Diseases.